Green Mountain Health Alliance Ltd. (“Green Mountain”, “GMHA” or the “Company”), an upcoming, large-scale, low-cost, quality medical cannabis wholesaler, is pleased to announce that it is proceeding with the planned construction of its cannabis facility located at 760 Highway 3A, Kaleden, BC.

The resumption of work comes as a result of ongoing discussion with the Agricultural Land Commission (“ALC”) and the receipt of a File Closure Letter from the ALC. After multiple property inspections taking place on August 15 and September 4, 2018, the ALC stated in a letter dated September 17, 2018, that they are “satisfied that the activity on the Property is in compliance with the Agricultural Land Commission legislation at this time.” The Company is currently a privately held entity and holds an application for a license under the Access to Cannabis for Medical Purposes Regulations (Canada) (“ACMPR”).


“We were ready to forge ahead with construction plans for our two-level administrative and nursery facility on Highway 3A when ALC regulations unexpectedly changed mid-July,” says company President, Wade Attwood. “With these legislative changes, our existing building design was considered ‘non-farm use’ under the new ALC regulations. We have since redesigned our buildings to meet our goals and also to comply with the new ALC ‘farm-use’ regulations.”

With a mission to cultivate large-scale, low-cost, high-quality medical cannabis, Green Mountain Health Alliance has secured two properties; one of which is a wholly owned 16-acre parcel on the Agricultural Land Reserve (ALR) in Kaleden, British Columbia.

“After the ALC’s new legislation was tabled, we have taken the time to discuss the changes with ALC officials, examine our company goals, and modify our plans to be in full compliance with the new regulations,” states Attwood. “From the start, our business model has centered on greenhouse growing, capitalizing on the abundant natural sunshine in the Okanagan Valley. We never intended on building ‘concrete bunkers’ for indoor cannabis production on ALR land, so modifying our plans was rather easy and will reduce construction costs in the long run.”

The company’s facility is planned with environmental sustainability and technology in mind and includes year-round rainwater capture and storage, closed-loop nutrient systems, and odour control mechanisms.

Attwood further states that “Our greenhouse facility will be state of the art and suitable to grow a variety of crops now and in the future, whether that is tomatoes, basil, or medical cannabis. We are looking forward to producing a high-quality medicinal product with great promise for many health conditions, all while creating jobs and contributing to the economic benefit and development of the Penticton area.”

Green Mountain is currently mid-stage of Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR) process.

About Green Mountain Health Alliance Ltd.: Green Mountain Health Alliance Ltd. (GMHA) is a capacity wholesale medical cannabis company, developing large-scale, low-cost production facilities in the Okanagan, B.C. The Company has applied to become a licensed cultivator, processor, and distributor of medical cannabis within Health Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”).

As a wholesale producer, GMHA aims to fill a gap in the Canadian cannabis market, effectively eliminating retail risk. The company has secured over 100 acres with the potential for over 1,000,000 square feet of growing space. The first site will be on a 16-acre parcel, located in Canada’s best growing area, the Okanagan.

Green Mountain’s experienced team and strong partnerships are focused on the cost-effective and efficient production of medical cannabis. The company is committed to best in class practices for low energy and sustainable production.

Grow Green.

The information contained herein contains “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements relate to information that is based on assumptions of management, forecasts of future results, and estimates of amounts not yet determinable. Any statements that express predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be “forward-looking statements.”  Forward-looking statements are subject to a variety of risks and uncertainties that could cause actual events or results to differ from those reflected in the forward-looking statements. Investors are cautioned against attributing undue certainty to forward-looking statements. These forward-looking statements are made as of the date hereof, and the Company does not assume any obligation to update or revise them to reflect new events or circumstances. Actual events or results could differ materially from the Company’s expectations or projections.

For further information:
Wade Attwood
President
wattwood@greenmountainhealthalliance.com
Dave Coolidge
VP Business Development
dcoolidge@greenmountainhealthalliance.com
Tel: (250) 486-5454
www.greenmountainhealthalliance.com

Source: www.newsfilecorp.com

US-based multi-state operators (MSOs) performed well during Q1, but one fund manager believes that hasn’t been reflected in their share prices.

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) announced today that its proprietary and patented combinatorial mushroom preparations AION F7 and AION F8 (collectively, the ” Aion Mushroom Preparations ” or ” Preparations “) showed high efficacy in killing HER2+ breast cancer cells, ER+PR+ breast cancer cells, and triple-negative breast cancer cells by direct cytotoxicity.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) (“Nextleaf”, “OILS”, or the “Company”) , the world’s most innovative cannabis processor, is pleased to announce that its wholly-owned subsidiary Nextleaf Labs Ltd. (“Nextleaf Labs” or “Labs”) has completed an inaugural bulk CBD distillate delivery to a U.S.-listed, Canadian-based global cannabis company. The Company anticipates similar orders on an ongoing basis.

Keep reading... Show less

The Company Will Tap into Southern Glazer’s Established Distribution Network to Bring Quatreau, its CBD-Infused Sparkling Water, to U.S. Retailers

 Canopy Growth Corporation (“Canopy Growth”) (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, CBD and vaporization device company, today announced Southern Glazer’s Wine & Spirits (“Southern Glazer’s”), the world’s pre-eminent distributor of beverage alcohol, as the distribution partner for its U.S. portfolio of CBD-infused beverages. This partnership announcement follows the recent launch of Quatreau Canopy’s first line of CBD-infused beverages sold in the U.S market.

Keep reading... Show less

 Canbud Distribution Corporation (CSE: CBDX) (FSE: CD0) (“Canbud” or the “Corporation”) announces its subsidiary Empathy Plant Co. has completed the full development of its vegan multivitamin formula exclusively for women.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7448/81051_95aa98db045cb95d_001.jpg
Unique Vegan Women’s Multi-Vitamin with 100% Compostable Packaging

Keep reading... Show less